Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis-Type Psoriasis”

216 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 216 results

Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT03131570
What this trial is testing

Safety and Efficacy of Secukinumab in Mild Psoriasis

Who this might be right for
Psoriasis
James G. Krueger, MD, PhD 23
Not applicableLooking for participantsNCT04751396
What this trial is testing

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Who this might be right for
Ankylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more
M.D. Anderson Cancer Center 125
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Post-approval studies (Phase 4)Study completedNCT01876875
What this trial is testing

N-3 Polysaturated Fatty Acids-rich Diet in Psoriasis

Who this might be right for
Plaque-type PsoriasisObesity (Body Mass Index >30 kg/m2)
Federico II University 44
Large-scale testing (Phase 3)Study completedNCT02471144
What this trial is testing

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Who this might be right for
Chronic Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 162
Testing effectiveness (Phase 2)UnknownNCT04117919
What this trial is testing

Psoriasis、Indigo Naturalis、Chinese Medicine Medicated Bath

Who this might be right for
Psoriasis
China Medical University Hospital 30
Post-approval studies (Phase 4)Study completedNCT00852761
What this trial is testing

Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

Who this might be right for
Plaque-Type Psoriasis
Stiefel, a GSK Company 34
Post-approval studies (Phase 4)Study completedNCT04720105
What this trial is testing

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Who this might be right for
Palmoplantar PsoriasisPlaque Psoriasis
Icahn School of Medicine at Mount Sinai 22
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT03848871
What this trial is testing

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Derm Research, PLLC 20
Not applicableStudy completedNCT00368784
What this trial is testing

T Cell Repertoire Analysis of Immune Mediated Skin Diseases

Who this might be right for
PsoriasisMycosis Fungoides
University of California, Davis 426
Early research (Phase 1)Study completedNCT02548052
What this trial is testing

Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis

Who this might be right for
Psoriasis
GlaxoSmithKline 15
Testing effectiveness (Phase 2)Study completedNCT00755196
What this trial is testing

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Who this might be right for
Psoriasis
Pfizer 30
Testing effectiveness (Phase 2)Study completedNCT02432040
What this trial is testing

Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis

Who this might be right for
Psoriasis
Philippine Dermatological Society 28
Not applicableLooking for participantsNCT07021495
What this trial is testing

SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more
Leiden University Medical Center 840
Not applicableStudy completedNCT07428954
What this trial is testing

Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care

Who this might be right for
DermatitisMelanoma (Skin Cancer)Alopecia+10 more
AI Labs Group S.L 16
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Large-scale testing (Phase 3)Study completedNCT02207244
What this trial is testing

Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 992
Post-approval studies (Phase 4)Ended earlyNCT00924950
What this trial is testing

Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasis Vulgaris
University of California, San Francisco 35
Next Page